OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Frequency Variation and Dose Modification of Benznidazole Administration for the Treatment of Trypanosoma cruzi Infection in Mice, Dogs, and Nonhuman Primates
Juan M. Bustamante, Brooke E. White, Gregory K. Wilkerson, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 5
Open Access | Times Cited: 16
Juan M. Bustamante, Brooke E. White, Gregory K. Wilkerson, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 5
Open Access | Times Cited: 16
Showing 16 citing articles:
New drug discovery strategies for the treatment of benznidazole-resistance in Trypanosoma cruzi , the causative agent of Chagas disease
Silvane Maria Fonseca Murta, Pedro Augusto Lemos Santana, Thibault Joseph William Jacques Dit Lapierre, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 6, pp. 741-753
Closed Access | Times Cited: 6
Silvane Maria Fonseca Murta, Pedro Augusto Lemos Santana, Thibault Joseph William Jacques Dit Lapierre, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 6, pp. 741-753
Closed Access | Times Cited: 6
System-based insights into parasitological and clinical treatment failure in Chagas disease
Linda M. Ernst, Giovana C. Macedo, Laura‐Isobel McCall
mSystems (2025)
Closed Access
Linda M. Ernst, Giovana C. Macedo, Laura‐Isobel McCall
mSystems (2025)
Closed Access
Positive clinical outcome using a modified dosing regimen of benznidazole in dogs at high risk for infection or acutely infected with Trypanosoma cruzi
Sukjung Lim, Stephanie Collins, Sarah A. Hamer, et al.
Journal of Veterinary Internal Medicine (2024) Vol. 38, Iss. 3, pp. 1725-1729
Open Access | Times Cited: 4
Sukjung Lim, Stephanie Collins, Sarah A. Hamer, et al.
Journal of Veterinary Internal Medicine (2024) Vol. 38, Iss. 3, pp. 1725-1729
Open Access | Times Cited: 4
The Unfortunate Abundance of Trypanosoma cruzi in Naturally Infected Dogs and Monkeys Provides Unique Opportunities to Advance Solutions for Chagas Disease
Rick L. Tarleton, Ashley B. Saunders, Bruno Lococo, et al.
Zoonoses (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 4
Rick L. Tarleton, Ashley B. Saunders, Bruno Lococo, et al.
Zoonoses (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 4
Serial ‘deep-sampling’ PCR of fragmented DNA reveals the wide range of Trypanosoma cruzi burden among chronically infected hosts and allows accurate monitoring of parasite load following treatment
Brooke E. White, Carolyn L. Hodo, Sarah A. Hamer, et al.
(2025)
Open Access
Brooke E. White, Carolyn L. Hodo, Sarah A. Hamer, et al.
(2025)
Open Access
Serial ‘deep-sampling’ PCR of fragmented DNA reveals the wide range of Trypanosoma cruzi burden among chronically infected hosts and allows accurate monitoring of parasite load following treatment
Brooke E. White, Carolyn L. Hodo, Sarah A. Hamer, et al.
(2025)
Open Access
Brooke E. White, Carolyn L. Hodo, Sarah A. Hamer, et al.
(2025)
Open Access
Effective drug discovery in Chagas disease
Rick L. Tarleton
Trends in Parasitology (2023) Vol. 39, Iss. 6, pp. 423-431
Closed Access | Times Cited: 12
Rick L. Tarleton
Trends in Parasitology (2023) Vol. 39, Iss. 6, pp. 423-431
Closed Access | Times Cited: 12
Animal models for exploring Chagas disease pathogenesis and supporting drug discovery
Archie A. Khan, Martin C. Taylor, Amanda Fortes Francisco, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 2
Archie A. Khan, Martin C. Taylor, Amanda Fortes Francisco, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 2
Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice
Shiromani Jayawardhana, Alexander I. Ward, Amanda Fortes Francisco, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 11, pp. e1011627-e1011627
Open Access | Times Cited: 6
Shiromani Jayawardhana, Alexander I. Ward, Amanda Fortes Francisco, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 11, pp. e1011627-e1011627
Open Access | Times Cited: 6
Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: an individual patient data meta-analysis of two proof of concept trials
James A Watson, Cintia Cruz, Fabiana Barreira, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
James A Watson, Cintia Cruz, Fabiana Barreira, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
cGAS–STING Pathway Activation during Trypanosoma cruzi Infection Leads to Tissue-Dependent Parasite Control
Natasha Perumal, Brooke E. White, Fernando Sánchez-Valdéz, et al.
The Journal of Immunology (2023) Vol. 211, Iss. 7, pp. 1123-1133
Closed Access | Times Cited: 2
Natasha Perumal, Brooke E. White, Fernando Sánchez-Valdéz, et al.
The Journal of Immunology (2023) Vol. 211, Iss. 7, pp. 1123-1133
Closed Access | Times Cited: 2
Validation of a multiplex microsphere immunoassay for detection of antibodies to Trypanosoma cruzi in dogs
Carlos A. Rodriguez, Rachel E. Busselman, Huifeng Shen, et al.
Journal of Veterinary Diagnostic Investigation (2023) Vol. 35, Iss. 6, pp. 704-709
Open Access | Times Cited: 2
Carlos A. Rodriguez, Rachel E. Busselman, Huifeng Shen, et al.
Journal of Veterinary Diagnostic Investigation (2023) Vol. 35, Iss. 6, pp. 704-709
Open Access | Times Cited: 2
Identification of host antioxidant effectors as thioridazine targets: Impact on cardiomyocytes infection and Trypanosoma cruzi-induced acute myocarditis
Elisa Domingues, Elda Gonçalves-Santos, Ivo Santana Caldas, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 6, pp. 167264-167264
Closed Access
Elisa Domingues, Elda Gonçalves-Santos, Ivo Santana Caldas, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 6, pp. 167264-167264
Closed Access
Serial ‘deep-sampling’ PCR of fragmented DNA reveals the wide range ofTrypanosoma cruziburden among chronically infected hosts and allows accurate monitoring of parasite load following treatment
Brooke E. White, Carolyn L. Hodo, Sarah A. Hamer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Brooke E. White, Carolyn L. Hodo, Sarah A. Hamer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Trypanosoma cruzipersisters that survive benznidazole treatmentin vitroandin vivoare in a transient non-replicative state
Shiromani Jayawardhana, Alexander I. Ward, Amanda Fortes Francisco, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Shiromani Jayawardhana, Alexander I. Ward, Amanda Fortes Francisco, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
